Baidu
map

儿童肾母细胞瘤诊疗规范(2019 年版)

2019-09-05 中华人民共和国国家卫生健康委员会 中华人民共和国国家卫生健康委员会官网

肾母细胞瘤是儿童时期最常见的肾脏恶性肿瘤,在所有儿童恶性肿瘤中约占6%;15 岁以下儿童中,发病率约为 7.1/100,000(美国),但亚洲人群中发病率略低;单侧肾母细胞瘤患儿中,男:女=0.92:1,平均诊断年龄为44 个月,大约10%的肾母细胞瘤伴有先天发育畸形。随着化疗、手术、放疗等多种治疗手段的综合应用,总体生存率已经达到85% 以上。目前,世界范围内肾母细胞瘤的治疗可分为两个类别,一是

中文标题:

儿童肾母细胞瘤诊疗规范(2019 年版)

发布日期:

2019-09-05

简要介绍:

肾母细胞瘤是儿童时期最常见的肾脏恶性肿瘤,在所有儿童恶性肿瘤中约占6%;15 岁以下儿童中,发病率约为 7.1/100,000(美国),但亚洲人群中发病率略低;单侧肾母细胞瘤患儿中,男:女=0.92:1,平均诊断年龄为44 个月,大约10%的肾母细胞瘤伴有先天发育畸形。随着化疗、手术、放疗等多种治疗手段的综合应用,总体生存率已经达到85% 以上。目前,世界范围内肾母细胞瘤的治疗可分为两个类别,一是以北美地区为首的COG,推荐直接手术治疗,根据术后病理和分期采取进一步治疗;二是以欧洲地区为首的SIOP,推荐术前化疗,待肿瘤缩小后再行手术切除,根据不同危险度来治疗;此两种治疗方式同样普遍存在于国内,故本规范将两者分别予以罗列,根据采用的初始治疗方式不同,各自选择使用治疗方案。

 

拓展指南:肾母细胞瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=儿童肾母细胞瘤诊疗规范(2019 年版))] GetToolGuiderByIdResponse(projectId=1, id=299011c001e933a3, title=儿童肾母细胞瘤诊疗规范(2019 年版), enTitle=, guiderFrom=中华人民共和国国家卫生健康委员会官网, authorId=null, author=, summary=肾母细胞瘤是儿童时期最常见的肾脏恶性肿瘤,在所有儿童恶性肿瘤中约占6%;15 岁以下儿童中,发病率约为 7.1/100,000(美国),但亚洲人群中发病率略低;单侧肾母细胞瘤患儿中,男:女=0.92:1,平均诊断年龄为44 个月,大约10%的肾母细胞瘤伴有先天发育畸形。随着化疗、手术、放疗等多种治疗手段的综合应用,总体生存率已经达到85% 以上。目前,世界范围内肾母细胞瘤的治疗可分为两个类别,一是, cover=, journalId=null, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Sep 05 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>肾母细胞瘤是儿童时期最常见的肾脏恶性肿瘤,在所有儿童恶性肿瘤中约占6%;15 岁以下儿童中,发病率约为 7.1/100,000(美国),但亚洲人群中发病率略低;单侧肾母细胞瘤患儿中,男:女=0.92:1,平均诊断年龄为44 个月,大约10%的肾母细胞瘤伴有先天发育畸形。随着化疗、手术、放疗等多种治疗手段的综合应用,总体生存率已经达到85% 以上。目前,世界范围内肾母细胞瘤的治疗可分为两个类别,一是以北美地区为首的COG,推荐直接手术治疗,根据术后病理和分期采取进一步治疗;二是以欧洲地区为首的SIOP,推荐术前化疗,待肿瘤缩小后再行手术切除,根据不同危险度来治疗;此两种治疗方式同样普遍存在于国内,故本规范将两者分别予以罗列,根据采用的初始治疗方式不同,各自选择使用治疗方案。</P> <P> </P>拓展指南:<strong>与<font color=red>肾母细胞瘤</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=7d76a1c001ae766e" title="儿童肾母细胞瘤诊断治疗建议(CCCG-WT-2016)" target=_blank>儿童肾母细胞瘤诊断治疗建议(CCCG-WT-2016)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=05cde1c001ae2702" title="儿童肾母细胞瘤病理诊断共识" target=_blank>儿童肾母细胞瘤病理诊断共识</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E8%82%BE%E6%AF%8D%E7%BB%86%E8%83%9E%E7%98%A4" target=_blank>有关肾母细胞瘤更多指南</a></ul>, tagList=[TagDto(tagId=3787, tagName=肾母细胞瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8327, appHits=267, showAppHits=0, pcHits=5282, showPcHits=4554, likes=54, shares=21, comments=5, approvalStatus=1, publishedTime=Fri Sep 20 00:15:24 CST 2019, publishedTimeString=2019-09-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Sep 20 00:15:24 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 11:27:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=儿童肾母细胞瘤诊疗规范(2019 年版))])
儿童肾母细胞瘤诊疗规范(2019 年版)
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1007117, encodeId=8f44100e11719, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=258a2211002, createdName=120d5e71m96(暂无昵称), createdTime=Wed Aug 11 22:50:47 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973062, encodeId=a6509e306271, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc3e5518268, createdName=ms3000002142555527, createdTime=Sat Jun 12 15:42:35 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896474, encodeId=aff58964e4b5, content=很好的学习方式, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f15d3890604, createdName=1381d648m98暂无昵称, createdTime=Tue Nov 03 07:55:12 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894002, encodeId=565d8940026a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/ce079fd0944b4af0896c4bdb2d547ac3/73f2f6c2202b43ceb43dd2354f7f73e6.jpg, createdBy=dfab5426678, createdName=ms2000001622015603, createdTime=Fri Oct 23 20:25:13 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2021-08-11 120d5e71m96(暂无昵称)

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1007117, encodeId=8f44100e11719, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=258a2211002, createdName=120d5e71m96(暂无昵称), createdTime=Wed Aug 11 22:50:47 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973062, encodeId=a6509e306271, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc3e5518268, createdName=ms3000002142555527, createdTime=Sat Jun 12 15:42:35 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896474, encodeId=aff58964e4b5, content=很好的学习方式, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f15d3890604, createdName=1381d648m98暂无昵称, createdTime=Tue Nov 03 07:55:12 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894002, encodeId=565d8940026a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/ce079fd0944b4af0896c4bdb2d547ac3/73f2f6c2202b43ceb43dd2354f7f73e6.jpg, createdBy=dfab5426678, createdName=ms2000001622015603, createdTime=Fri Oct 23 20:25:13 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2021-06-12 ms3000002142555527

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1007117, encodeId=8f44100e11719, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=258a2211002, createdName=120d5e71m96(暂无昵称), createdTime=Wed Aug 11 22:50:47 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973062, encodeId=a6509e306271, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc3e5518268, createdName=ms3000002142555527, createdTime=Sat Jun 12 15:42:35 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896474, encodeId=aff58964e4b5, content=很好的学习方式, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f15d3890604, createdName=1381d648m98暂无昵称, createdTime=Tue Nov 03 07:55:12 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894002, encodeId=565d8940026a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/ce079fd0944b4af0896c4bdb2d547ac3/73f2f6c2202b43ceb43dd2354f7f73e6.jpg, createdBy=dfab5426678, createdName=ms2000001622015603, createdTime=Fri Oct 23 20:25:13 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-11-03 1381d648m98暂无昵称

    很好的学习方式

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1007117, encodeId=8f44100e11719, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=258a2211002, createdName=120d5e71m96(暂无昵称), createdTime=Wed Aug 11 22:50:47 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973062, encodeId=a6509e306271, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc3e5518268, createdName=ms3000002142555527, createdTime=Sat Jun 12 15:42:35 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896474, encodeId=aff58964e4b5, content=很好的学习方式, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f15d3890604, createdName=1381d648m98暂无昵称, createdTime=Tue Nov 03 07:55:12 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894002, encodeId=565d8940026a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201016/ce079fd0944b4af0896c4bdb2d547ac3/73f2f6c2202b43ceb43dd2354f7f73e6.jpg, createdBy=dfab5426678, createdName=ms2000001622015603, createdTime=Fri Oct 23 20:25:13 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-10-23 ms2000001622015603

    学习

    0

Baidu
map
Baidu
map
Baidu
map